Clinical characteristics of zinc phosphide poisoning in Thailand
- PMID: 28352183
- PMCID: PMC5360397
- DOI: 10.2147/TCRM.S129610
Clinical characteristics of zinc phosphide poisoning in Thailand
Abstract
Objective: The objectives of this study were to describe the clinical characteristics and outcomes of poisoning by zinc phosphide, a common rodenticide in Thailand, and to evaluate whether these outcomes can be prognosticated by the clinical presentation.
Materials and methods: A 3-year retrospective cohort study was performed using data from the Ramathibodi Poison Center Toxic Exposure Surveillance System.
Results: In total, 455 poisonings were identified. Most were males (60.5%) and from the central region of Thailand (71.0%). The mean age was 39.91±19.15 years. The most common route of exposure was oral (99.3%). Most patients showed normal vital signs, oxygen saturation, and consciousness at the first presentation. The three most common clinical presentations were gastrointestinal (GI; 68.8%), cardiovascular (22.0%), and respiratory (13.8%) signs and symptoms. Most patients had normal blood chemistry laboratory results and chest X-ray findings at presentation. The median hospital stay was 2 days, and the mortality rate was 7%. Approximately 70% of patients underwent GI decontamination, including gastric lavage and a single dose of activated charcoal. In all, 31 patients were intubated and required ventilator support. Inotropic drugs were given to 4.2% of patients. Four moribund patients also received hyperinsulinemia-euglycemia therapy and intravenous hydrocortisone; however, all died. Patients who survived and died showed significant differences in age, duration from taking zinc phosphide to hospital presentation, abnormal vital signs at presentation (tachycardia, low blood pressure, and tachypnea), acidosis, hypernatremia, hyperkalemia, in-hospital acute kidney injury, in-hospital hypoglycemia, endotracheal tube intubation, and inotropic requirement during hospitalization (P<0.05).
Conclusion: Zinc phosphide poisoning causes fatalities. Most patients have mild symptoms, and GI symptoms are the most common. Patients who present with abnormal vital signs or electrolytes might have more severe poisoning and should be closely monitored and aggressively treated. All patients should be observed in the hospital for 2 days and followed up for cardiovascular and respiratory symptoms, electrolyte balances, kidney function, and blood glucose.
Keywords: clinical characteristic; outcome; poisoning; zinc phosphide.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Similar articles
-
Emamectin Poisoning in Thailand: Clinical Characteristics and Outcomes.Toxics. 2024 Sep 13;12(9):668. doi: 10.3390/toxics12090668. Toxics. 2024. PMID: 39330596 Free PMC article.
-
Potential zinc phosphide rodenticide toxicosis in dogs: 362 cases (2004-2009).J Am Vet Med Assoc. 2011 Sep 1;239(5):646-51. doi: 10.2460/javma.239.5.646. J Am Vet Med Assoc. 2011. PMID: 21879965
-
A case report of zinc phosphide poisoning: complicated by acute renal failure and tubulo interstitial nephritis.BMC Pharmacol Toxicol. 2017 May 25;18(1):37. doi: 10.1186/s40360-017-0144-7. BMC Pharmacol Toxicol. 2017. PMID: 28545504 Free PMC article.
-
Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.Clin Toxicol (Phila). 2007;45(3):203-33. doi: 10.1080/15563650701226192. Clin Toxicol (Phila). 2007. PMID: 17453872
-
Zinc Phosphide Poisoning: From A to Z.Toxics. 2023 Jun 25;11(7):555. doi: 10.3390/toxics11070555. Toxics. 2023. PMID: 37505522 Free PMC article. Review.
Cited by
-
'Toxic' ST elevation.BMJ Case Rep. 2018 Jun 27;2018:bcr2017221457. doi: 10.1136/bcr-2017-221457. BMJ Case Rep. 2018. PMID: 29950357 Free PMC article. No abstract available.
-
Human Zinc Phosphide Exposure in Lebanon: A Case Report and Review of the Literature.Clin Pract Cases Emerg Med. 2021 Feb;5(1):50-57. doi: 10.5811/cpcem.2020.10.47397. Clin Pract Cases Emerg Med. 2021. PMID: 33560952 Free PMC article.
-
Acute liver failure secondary to yellow phosphorus rodenticide poisoning: Outcomes at a center with dedicated liver intensive care and transplant unit.J Clin Exp Hepatol. 2020 Oct 8;11(4):424-34. doi: 10.1016/j.jceh.2020.09.010. Online ahead of print. J Clin Exp Hepatol. 2020. PMID: 33052182 Free PMC article.
-
Butyrylcholinesterase level in poisoned patients with phosphide compounds.Caspian J Intern Med. 2019 Fall;10(4):458-462. doi: 10.22088/cjim.10.4.458. Caspian J Intern Med. 2019. PMID: 31814946 Free PMC article.
-
Liver Transplantation Society of India Guidelines for the Management of Acute Liver Injury Secondary to Yellow Phosphorus-Containing Rodenticide Poisoning Using the Modified Delphi Technique of Consensus Development.J Clin Exp Hepatol. 2021 Jul-Aug;11(4):475-483. doi: 10.1016/j.jceh.2020.09.011. Epub 2020 Oct 6. J Clin Exp Hepatol. 2021. PMID: 34276154 Free PMC article.
References
-
- Proudfoot AT. Aluminium and zinc phosphide poisoning. Clin Toxicol (Phila) 2009;47(2):89–100. - PubMed
-
- Bumbrah GS, Krishan K, Kanchan T, Sharma M, Sodhi GS. Phosphide poisoning: a review of literature. Forensic Sci Int. 2012;214(1–3):1–6. - PubMed
-
- Chugh SN, Aggarwal HK, Mahajan SK. Zinc phosphide intoxication symptoms: analysis of 20 cases. Int J Clin Pharmacol Ther. 1998;36(7):406–407. - PubMed
-
- Hassanian-Moghaddam H, Shahnazi M, Zamani N, Rahimi M, Bahrami-Motlagh H, Amiri H. Plain abdominal radiography: a powerful tool to prognosticate outcome in patients with zinc phosphide poisoning. Clin Radiol. 2014;69(10):1062–1065. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources